Scleroderma, Systemic Completed Phase 3 Trials for Cyclophosphamide (DB00531)

Also known as: Systemic Scleroderma

IndicationStatusPhase
DBCOND0028174 (Scleroderma, Systemic)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004563Scleroderma Lung DiseasePrevention